globalnews.ca
77%
331
Potential COVID-19 vaccine still not in Canada, three months after approval for trials
COVID-19 candidate vaccine remain delayed from getting to Canada, more than three months after Health Canada approved them for Phase 1 trials here.The Ad5-nCoV potential vaccine is being produced at CanSino Biologics in Tianjin, China, and uses cell lines developed at the National Research Council of Canada (NRC).Researchers at Dalhousie University’s Canadian Center for Vaccinology were set to test the CanSino product in Phase 1 trials in Halifax as early as late May.Ad5-nCoV has already completed relatively promising Phase 2 trials within China. In June, it was approved for use in the People’s Liberation Army – China’s armed forces.A Chinese patent was granted for Ad5-nCoV this month, and Phase 3, large-scale trials — which include people